Filters

From patient classification to optimized treatment in ART: the AMPLITUDE Delphi consensus

Blockeel C, Guivarc'h-Leveque A, Rongieres C, et al.

2024

Frontiers in Reproductive Health

No Guarantees: Planned Oocyte Cryopreservation, Not Quite an Insurance Policy

Klipstein S, Kelly L, Lalwani S

2024

Archives of Gynecology and Obstetrics

Patterns of Utilization of Advanced Practice Providers in Reproductive Endocrinology: a 2023 National Survey

Tobias T, Callahan N, Augustine L, et al.

2024

Fertility & Sterility Reports

Analysis of nurse and patient Preferences for pre-filled pen devices for self-injection of highly purified human menopausal gonadotropin (HP-hMG, MENOPUR®)

De Mesmaeker G, Calles B, Smith J.

2023

Patient Prefer Adherence

Highly purified human menopausal gonadotropin (HP-hMG) versus recombinant follicle-stimulating hormone (rFSH) for controlled ovarian stimulation in US ...

Khair A, Brown T, Markert M, et al.

2023

Pharmacoecon Open

First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for ...

Jonker DM, Koch M, Larsson P, et al.

2021

Int J Clin Pharmacol Ther

Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing ...

Witz C, Daftary G, Doody K, et al.

2020

Fertil Steril

Patient experience in a randomized trial of a weekly progesterone vaginal ring versus a daily progesterone gel for luteal support after in vitro fertilization

Ginsburg E, Jellerette-Nolan T, Daftary G, et al.

2018

Fertil Steril

Frozen-thawed embryo transfer in a natural or mildly hormonally stimulated cycle in women with regular ovulatory cycles: a RCT

Peeraer K, Couck I, Debrock S, et al.

2015

Hum Repro

Patients' administration preferences: progesterone vaginal insert (Endometrin® compared to intramuscular progesterone for luteal phase support

Beltsos A, Sanchez M, Doody K, et al.

2014

Reprod Health

Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF

Paulson R, Collins M, Yankov V.

2014

J Clin Endocrinol Metab

Clinical comparison of ovarian stimulation and luteal support agents in patients undergoing GnRH antagonist IVF cycles

Miller C, Zbella E, Webster B, et al.

2013

J Reprod Med

Early versus late hCG administration to trigger ovulation in mild stimulated IUI cycles: A randomized clinical trial

Da Silva A, Arbo E, Fanchin R.

2012

Eur J Obstet Gynecol Reprod Biol

A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer

Devroey P, Pellicer A, Nyboe Andersen A, et al.

2012

Fertil Steril

Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trial

García-Velasco J, Kupesic S, Pellicer A, et al.

2011

Reprod Biomed Online

Endometrin for luteal phase support in a randomized, controlled, open-label, prospective in-vitro fertilization trial using a combination of Menopur and ...

Doody K, Schnell V, Foulk R, et al.

2009

Fertil Steril

Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients

Smitz J, Nyobe Andersen A, Devroey P, et al.

2007

Hum Repro

Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF

Ziebe S, Lundin K, Janssens R, et al.

2007

Hum Repro

Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial

Nyboe Andersen A, Devroey P, Arce JC.

2006

Hum Repro

Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection ...

European and Israeli Study Group.

2002

Fertil Steril

Improved intravaginal controlled-release prostaglandin E2 insert for cervical ripening at term

Witter F, Mercer B.

1996

J Matern Fetal Med

A randomized trial of prostaglandin E2 in a controlled-release vaginal pessary for cervical ripening at term

Witter F, Rocco L, Johnson T.

1992

Am J Obstet Gynecol

Explore More

MIRF
SUBMIT MEDICAL INFORMATION REQUEST 
Can’t find the information you are looking for? Would you like a copy of the full-text publication?
congress
CONGRESSES
What congress material is available for this therapy area?